Neurocovid-19: A clinical neuroscience-based approach to reduce SARS-CoV-2 related mental health sequelae

Stefano Pallanti, Eleonora Grassi, Nikos Makris, Gregory P. Gasic, Eric Hollander

Research output: Contribution to journalArticle

Abstract

Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, is a disaster due to not only its psychosocial impact but it also to its direct effects on the brain. The latest evidence suggests it has neuroinvasive mechanisms, in addition to neurological manifestations, and as seen in past pandemics, long-term sequelae are expected. Specific and well-structured interventions are necessary, and that's why it's important to ensure a continuity between primary care, emergency medicine, and psychiatry. Evidence shows that 2003 SARS (Severe Acute Respiratory Syndrome) survivors developed persistent psychiatric comorbidities after the infection, in addition to Chronic Fatigue Syndrome. A proper stratification of patients according not only to psychosocial factors but also an inflammatory panel and SARS-Cov-2's direct effects on the central nervous system (CNS) and the immune system, may improve outcomes. The complexity of COVID-19's pathology and the impact on the brain requires appropriate screening that has to go beyond the psychosocial impact, taking into account how stress and neuroinflammation affects the brain. This is a call for a clinical multidisciplinary approach to treat and prevent Sars-Cov-2 mental health sequelae.

Original languageEnglish (US)
Pages (from-to)215-217
Number of pages3
JournalJournal of Psychiatric Research
Volume130
DOIs
StatePublished - Nov 2020

Keywords

  • Coronavirus
  • COVID-19
  • Mental health
  • Neurocovid
  • Psychosocial support
  • SARS-COV-2

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint Dive into the research topics of 'Neurocovid-19: A clinical neuroscience-based approach to reduce SARS-CoV-2 related mental health sequelae'. Together they form a unique fingerprint.

  • Cite this